Overview

AvenovaTM as a Sterile Skin Preparation Agent

Status:
Completed
Trial end date:
2019-12-20
Target enrollment:
0
Participant gender:
All
Summary
Aim 1: To determine in vivo capability of AvenovaTM against common cutaneous microbial biome on human skin Aim 2: To compare to povidone-iodine 5% solution, 4% chlorhexidine and isopropyl alcohol against AvenovaTM as a sterile skin agent
Phase:
Early Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Miami
Treatments:
Chlorhexidine
Chlorhexidine gluconate
Ethanol
Iodine
Pharmaceutical Solutions
Povidone
Povidone-Iodine
Criteria
Inclusion Criteria:

- Adults age 18 and above able to provide informed consent to participate Adults
attending Dr. Wendy Lee Oculoplastics Clinic

Exclusion Criteria:

- Adults unable to consent

- Individuals who less than 18 years of age

- Prisoners

- Pregnant women - while these cleansing agents are used on pregnant women as standard
cleansing agents, effects to fetus unknown

- Patients currently using oral or topical antimicrobial agents

- History of skin infection to facial injectable of surgery

- Inability to tolerate cleansing procedure

- Inability to sit comfortably for 15 - 30 minutes